ArticleFrontiers in medicine2026

Dickkopf 2 serves as a novel therapeutic target and prognostic biomarker in acute myeloid leukemia targeted by evodiamine.

Rui Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.